FIGURE 5.
Median local recurrence-free survival (L-RFS) was 21.4 months (95% CI 15.3–27.4). A, L-RFS was similar between FLX and GNP groups. B and C, L-RFS was superior in patients with marked biochemical response (≥50% decline) and pCR.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.